Introduction Acinetobacter baumannii is a gram-negative, opportunistic pathogen
responsible for resistant nosocomial infections especially in the intensive care units (ICUS) …

Multidrug-resistant Acinetobacter baumannii infections are serious challenges for clinicians
because of A. baumannii propensity to acquire resistance to a wide spectrum of …

The study was performed to detect the in vitro activity of tigecycline in multidrug-resistant
Acinetobacter isolates from patients in Hacettepe University Adult Hospital, Turkey. The …

Acinetobacter baumannii is an important opportunistic pathogen due to its capabilities for
developing mechanisms of resistance to a wide range of antimicrobial agents including …

Colistin is one of the last remaining active antibiotics against multidrug resistant Gram-
negative bacteria. However, several recent studies reported colistin-resistant (ColR) …

Objectives To determine the in vitro activities and interactions of imipenem, colistin and
tigecycline with old antibacterial agents against carbapenem-resistant Acinetobacter …

Background The presence of multi-drug resistant Acinetobacter baumannii raises a big
therapeutic challenge in our hospital. Tigecycline, a new glycylcycline with expanded broad …

Background Nosocomial infections due to multi-drug resistant Acinetobacter baumannii are
often treated with colistin, but there are few data comparing its safety and efficacy with other …

To the Editor—Rolain et al [1] report a patient colonized with a colistinresistant Acinetobacter
baumannii strain after colistin therapy without clinical signs of infection, pointing out the low …

This study was conducted to determine the prevalence and the local antibiogram of
multidrug-resistant Acinetobacter baumannii isolates in Al-Hussein Hospital at King Hussein …